Latest news for Everest Metals Corp (OTC:URRNF) Stock

Everest Metals Corp Ltd is a company exploring economic deposits containing Cobalt in prospective areas within stable jurisdictions. Cobalt is a strategic mineral and an essential element used in batteries important for the growth of renewable energy in the world. The projects of the company include Revere; Mt Dimer; Rover; Yarbu; Ninghan and Mt Edon.

EVEREST METALS CORP LTD by EVEREST METALS CORP LTD.

Everest Metals Corp Ltd

WIIM

FSLR

First Solar shares are trading higher after the company announced that it commissioned a new research and development innovation center in Lake Township, Ohio.

RBC Capital analyst Ben Hendrix maintains Elevance Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) with a Outperform and raises the price target from $575 to $585.

News

Price Target

Analyst Ratings

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

RBC Capital Maintains Outperform on Elevance Health, Raises Price Target to $585

Equifax shares are trading higher after the company reported better-than-expected Q2 financial results. Also, B of A Securities maintained a buy rating on the stock and raised its price target from $255 to $286.

Jones Soda Co. (CSE:&nbsp;JSDA) (QTCQB: JSDA) announced on Thursday&nbsp;that it has upsized its private placement of units.
The Seattle-based company <a href="https://www.benzinga.com/markets/cannabis/24/07/39728726/weed-infused-innovator-jones-soda-launches-3m-offering">first announced</a> a private placement of up to 7,500,000 units for 40 cents per unit, for a total gross proceeds of $3 million last week, only to increase the size of its private placement shortly after. According to a July 11 press release, Jones Soda said it will issue up to 10,000,000 units of the company for $0.40&nbsp;per unit, for&nbsp;aggregate&nbsp;gross proceeds&nbsp;of $4 million.
The company now intends to issue up to a maximum of 12,500,000 of its units for $0.40&nbsp;per unit, for&nbsp;aggregate gross&nbsp;proceeds&nbsp;of up to $5 million, according to Thursday's press release.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/05/38720056/cannabis-infused-innovator-jones-soda-co-partners-with-street-league-skateboarding-in-multi-year">Cannabis-Infused Innovator Jones Soda Co. Partners With Street League Skateboarding In Multi-Year Deal</a>
<h3 class="wp-block-heading">Details</h3>
Each&nbsp;unit&nbsp;will comprise one&nbsp;common share&nbsp;in&nbsp;the&nbsp;capital&nbsp;of&nbsp;the&nbsp;company and one‐half of one detachable share purchase warrant. Each whole warrant will be exercisable into one common share at $0.50 per share for 24 months from the date of issuance.
Additionally, each whole warrant may be exercised anytime during the warrant exercise period upon the voluntary election to exercise by the warrant holder, the company said.
<h3 class="wp-block-heading">Why It Matters</h3>
Jones Soda said it intends to use the net proceeds of the offering to support growth and for general corporate purposes.
<h3 class="wp-block-heading">What's Next</h3>
The company expects to close the offering on or about July 23, 2024. It is subject to certain conditions&nbsp;including,&nbsp;but&nbsp;not&nbsp;limited to,&nbsp;the&nbsp;receipt&nbsp;of&nbsp;all&nbsp;necessary&nbsp;regulatory&nbsp;approvals&nbsp;including the approval of the CSE.
<h3 class="wp-block-heading">JSDA Price Action</h3>
Jones Soda shares closed Wednesday&#8217;s market session 4.14% higher at 44 cents per share.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/05/38839707/jones-sodas-marijuana-drinks-bring-in-200-higher-q1-revenue-co-eyes-expansion-and-praises-new-he">Jones Soda&#8217;s Marijuana Drinks Bring In 200% Higher Q1 Revenue, Co. Eyes Expansion And Praises New Hemp Delta-9 Products</a></li>
</ul>
To keep on top of what is happening with cannabis stocks and everything across the industry, join us at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.&nbsp;<a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">Get your tickets now</a> before prices go up by following&nbsp;<a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank" rel="noreferrer noopener">this link</a>.

Cannabis

Financing

JSDA

Weed-Infused Innovator Jones Soda Upsizes Its Private Placement To $5M

Contracts

APDN

Applied DNA Sciences Says U.S. Defense Logistics Agency Exercises 1-year Option Period In Applied DNA Counterfeit Mitigation Contract

TWFG

Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

MSFT

OpenAI Debuts Mini AI Model Named "GPT-4o Mini"

Discover Financial Services shares are trading higher after the company reported better-than-expected Q2 EPS results.

Federal Reserve

Fed's Goolsbee Says We've Had Multiple Months Of Better Inflation Data; Inflation Fight Is Not Done, But I Feel A Lot Better; Labor Market Has Been Cooling To Better Balance

RBC Capital analyst Jon Arfstrom maintains First Horizon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FHN#NYSE">FHN</a>) with a Outperform and raises the price target from $18 to $19.

RBC Capital Maintains Outperform on First Horizon, Raises Price Target to $19

Blackstone shares are trading higher following Q2 earnings.

AAPL

Apple In Talks To License More Films From Hollywood

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 40 points on Thursday.
Following the market opening Thursday, the Dow traded up 0.10% to 41,238.64 while the NASDAQ rose 0.22% to 18,036.66. The S&amp;P 500 also rose, gaining, 0.21% to 5,600.18.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/07/39835740/top-3-health-care-stocks-which-could-rescue-your-portfolio-in-july">Top 3 Health Care Stocks Which Could Rescue Your Portfolio In July</a>
Leading and Lagging Sectors Industrials shares jumped by 0.6% on Thursday.
In trading on Thursday, health care shares fell by 0.4%.
Top Headline
D.R. Horton, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHI#NYSE">DHI</a>) reported better-than-expected second-quarter earnings on Thursday.
D.R. reported quarterly earnings of $4.10 per share which beat the analyst consensus estimate of $3.78 per share. The company reported quarterly sales of $9.966 billion which beat the analyst consensus estimate of $9.771 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Onconetix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCO#NASDAQ">ONCO</a>) shares shot up 85% to $0.2761. On July 15, Onconetix announced closing of warrant exercise for $1.11 million gross proceeds.</li>
<li>Shares of Silo Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILO#NASDAQ">SILO</a>) got a boost, surging 66% to $3.74. Silo Pharma said it has entered into a Device and CMC Development Master Plan with Resyca BV, a medical technology provider.</li>
<li>Chuy&#8217;s Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHUY#NASDAQ">CHUY</a>) shares were also up, gaining 48% to $37.35 after Darden Restaurants announced it will acquire the company.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Agenus Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGEN#NASDAQ">AGEN</a>) shares dropped 54% to $8.17 after the company announced the FDA discouraged an accelerated approval pathway at the end-of-Phase 2 meeting.</li>
<li>Shares of Leslie&#8217;s, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) were down 30% to $2.8699 after the company reported preliminary financial results for the third quarter and cut its full-year guidance. Multiple analysts also lowered price targets on the stock Thursday morning.</li>
<li>Fitell Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTEL#NASDAQ">FTEL</a>) was down, falling 22% to $21.00.</li>
</ul>
Also Check This Out: <a href="https://www.benzinga.com/news/24/07/39835744/nvidia-electronic-arts-and-2-other-stocks-insiders-are-selling">Nvidia, Electronic Arts And 2 Other Stocks Insiders Are Selling</a>
Commodities In commodity news, oil traded down 0.3% to $82.60 while gold traded up 0.3% at $2,467.00.
Silver traded up 0.6% to $30.565 on Thursday, while copper fell 2.1% to $4.3175.
Euro zone
European shares were higher today. The eurozone's STOXX 600 rose 0.6%, Germany's DAX rose 0.4% and France's CAC 40 rose 0.9%. Spain's IBEX 35 Index rose 0.9%, while London's FTSE 100 rose 0.8%.
Construction output in the Eurozone fell 2.4% year-over-year in May compared to a revised 1.5% decline in the prior month. Passenger car registrations in the European Union climbed 4.3% year-over-year to 1.1 million units in June.
Regular pay in the U.K., excluding bonus payment, rose 5.7% year-over-year to GBP 643/week during the three months to May, while the unemployment rate came in unchanged at 4.4% from March to May.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei 225 dipping 2.36%, Hong Kong's Hang Seng Index gaining 0.22%, China's Shanghai Composite Index gaining 0.48% and India's S&amp;P BSE Sensex climbing 0.78%.
Hong Kong&#8217;s unemployment rate came in unchanged at 3% during the three months ending June. Japan reported a trade surplus of JPY 224.04 billion in June, compared to market views for a deficit of JPY 240 billion.
Economics
<ul>
<li>U.S. initial jobless claims increased by 10,000 to 243,000 in the week ending July 13, compared to market estimates of 230,000.</li>
<li>The Philadelphia Fed Manufacturing Index rose to 13.9 in July, recording the strongest level in three months, versus 1.3 in June.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39836829/how-to-earn-500-a-month-from-american-express-stock-ahead-of-q2-earnings">How To Earn $500 A Month From American Express Stock Ahead Of Q2 Earnings</a></li>
</ul>

Earnings

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

AGEN

CHUY

FTEL

LESL

ONCO

SILO

US Stocks Edge Higher; D.R. Horton Posts Upbeat Earnings

Crypto
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39835766/dogecoin-killer-shiba-inu-burn-rate-up-875-but-price-down-10-what-is-going-on">&#8216;Dogecoin Killer&#8217; Shiba Inu Burn Rate Up 875% But Price Down 10%: What Is Going On?</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39835533/wazirx-suffers-230m-hack-suspends-withdrawals-amid-security-breach">WazirX Suffers $230M Hack, Suspends Withdrawals Amid Security Breach</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39835531/bitcoin-spot-etfs-continue-inflow-streak-but-whats-up-with-this-technical-indicator">Bitcoin Spot ETFs Continue Inflow Streak&#8230;But What&#8217;s Up With This Technical Indicator?</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39832804/as-stablecoin-inflows-surge-to-all-time-highs-heres-what-it-could-mean-for-bitcoin-and-cry">As Stablecoin Inflows Surge To All-Time Highs, Here&#8217;s What It Could Mean For Bitcoin And Crypto Market</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39830636/analysts-question-strategy-behind-high-fees-of-grayscale-ethereum-spot-etf-they-seem-focus">Analysts Question Strategy Behind High Fees Of Grayscale Ethereum Spot ETF: They Seem Focused On &#8216;Maximizing Short-Term Revenue Vs Playing Long Game&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39829989/bitcoin-ethereum-dogecoin-decline-amid-tech-stock-bloodbath-analyst-says-king-crypto-not-q">Bitcoin, Ethereum, Dogecoin Decline Amid Tech Stock Bloodbath: Analyst Says King Crypto &#8216;Not Quite Ready Just Yet&#8217; For This Price Level</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/39829658/odds-of-biden-dropping-out-of-race-surge-to-66-pollster-nate-silver-joins-crypto-based-pre">Odds of Biden Dropping Out Of Race Surge To 66% — Pollster Nate Silver Joins Crypto-Based Prediction Market Polymarket</a></li>
</ul>
US Politics
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39829608/trump-rally-security-secret-service-was-informed-of-police-inability-to-watch-sniper-location">Trump Rally Security: Secret Service Was Informed Of Police Inability To Watch Sniper Location</a></li>
<li><a href="https://www.benzinga.com/24/07/39829417/biden-gets-covid-19-takes-a-fiesty-dig-at-tesla-ceo-im-sick-of-elon-musk-and-his-rich-buddies-trying">Biden Gets COVID-19, Takes A Fiesty Dig At Tesla CEO: &#8216;I&#8217;m Sick …Of Elon Musk And His Rich Buddies Trying To Buy This Election&#8217;</a></li>
</ul>
US Markets
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39836738/leslies-issues-preliminary-financial-results-joins-beyond-meat-dominos-and-other-big-stocks-moving-l">Leslie&#8217;s Issues Preliminary Financial Results, Joins Beyond Meat, Domino&#8217;s And Other Big Stocks Moving Lower In Thursday&#8217;s Pre-Market Session</a></li>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39835373/wall-street-gearing-up-for-tech-led-rebound-ahead-of-netflix-earnings-economist-expects-soft-landin">Wall Street Gearing Up For Tech-Led Rebound Ahead Of Netflix Earnings: Economist Expects Soft Landing But Says Brace For Bigger Fed Rate Cuts If This Happens</a></li>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39831773/nasdaq-sees-worst-session-since-2022-as-chip-stocks-tumble-after-trumps-taiwan-remarks-and-bidens-p">Nasdaq Sees Worst Session Since 2022 As Chip Stocks Tumble After Trump&#8217;s Taiwan Remarks and Biden&#8217;s Potential Restrictions</a></li>
</ul>
World Politics
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39832267/china-halts-nuclear-talks-with-us-over-taiwan-arms-sales-after-reportedly-sanctioning-lockheed-marti">China Halts Nuclear Talks With US Over Taiwan Arms Sales After Reportedly Sanctioning Lockheed Martin Executives In June</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39829923/trumps-taiwan-talk-bidens-trade-restriction-plans-trigger-nvidia-amd-and-other-semiconductor-sel">Trump&#8217;s Taiwan Talk, Biden&#8217;s Trade Restriction Plans Trigger Nvidia, AMD And Other Semiconductor Selloff: &#8216;I&#8217;m Having Flashbacks,&#8217; Says Analyst</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39829916/xi-jinpings-china-is-putting-worlds-most-stringent-regulations-on-ai-tech-giants-alibaba-bytedance-t">Xi Jinping&#8217;s China Is Putting World&#8217;s Most Stringent Regulations On AI — Tech Giants Alibaba, ByteDance Test Tech For Compliance With Socialist Values</a></li>
</ul>
US Economy
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39830062/september-may-bring-rate-cut-says-former-dallas-fed-president-robert-kaplan-i-think-theres-a-good-ch">September May Bring Rate Cut, Says Former Dallas Fed President Robert Kaplan: &#8216;I Think There&#8217;s A Good Chance&#8230;&#8217;</a></li>
</ul>
Tech
<ul>
<li><a href="Palantir%20Stock%20Up%20Over%2060%25%20This%20Year,%20But%20Analyst%20Says%20The%20Story%20Remains%20'Very%20Undervalued%20And%20Misunderstood%20By%20The%20Street'">Palantir Stock Up Over 60% This Year, But Analyst Says The Story Remains &#8216;Very Undervalued And Misunderstood By The Street&#8217;</a></li>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39836500/infosys-reports-strong-q1-earnings-records-highest-free-cash-flow-ever">Infosys Reports Strong Q1 Earnings, Records Highest Free Cash Flow Ever</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39835993/apple-denies-using-youtube-videos-to-train-its-ai-features-after-report-claims-tim-cooks-company-use">Apple Denies Using YouTube Videos To Train Its AI Features After Report Claims Tim Cook&#8217;s Company Used Creators&#8217; Content Without Consent</a></li>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39834407/nokias-q2-earnings-record-low-revenue-as-5g-investment-slows-annual-outlook-cut-stock-slides/">Nokia&#8217;s Q2 Earnings: Record-Low Revenue As 5G Investment Slows, Annual Outlook Cut, Stock Slides</a></li>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39833542/apple-nvidia-supplier-tsmc-stock-rises-in-thursdays-premarket-after-crashing-8-in-last-session-what">Apple, Nvidia Supplier TSMC Stock Rises In Thursday&#8217;s Premarket After Crashing 8% In Last Session: What&#8217;s Driving The Rebound?</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39832782/figma-bags-new-investment-at-12-5b-valuation-nearly-40-lower-than-the-terminated-20b-adobe-deal">Figma Bags New Investment At $12.5B Valuation, Nearly 40% Lower Than The Terminated $20B Adobe Deal</a></li>
<li><a href="https://www.benzinga.com/markets/asia/24/07/39832197/apple-nvidia-supplier-tsmc-reports-strong-q2-results-amid-booming-demand-for-ai-chips-guides-q3-abov">Apple, Nvidia Supplier TSMC Reports Strong Q2 Results Amid Booming Demand For AI Chips, Guides Q3 Above Consensus: 2024 To Be &#8216;Strong Growth Year,&#8217; Says CEO</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39830846/microsoft-outpaces-apple-introduces-designer-ai-image-generation-tool-for-the-iphone">Microsoft Outpaces Apple, Introduces &#8216;Designer&#8217; AI Image Generation Tool For The iPhone</a></li>
</ul>
Electric Vehicle
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39835681/whats-going-on-with-nio-shares-thursday">What&#8217;s Going On With NIO Shares Thursday?</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39833218/tesla-ford-lose-market-share-in-eu-even-as-overall-car-registrations-rise-toyota-and-other-japanese">Tesla, Ford Lose Market Share In EU Even As Overall Car Registrations Rise: Toyota And Other Japanese Players Gain</a></li>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/07/39833163/trump-vance-administration-will-be-terrible-for-tesla-says-bear-elon-musk-has-compl">Trump-Vance Administration Will Be &#8216;Terrible&#8217; For Tesla, Says Bear: Elon Musk &#8216;Has Completely Alienated Most Of His Buying Base&#8217;</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39832499/tesla-executive-assures-cybertruck-light-bar-coming-soon-for-foundation-series-cyberbeast-customers">Tesla Executive Assures Cybertruck Light Bar Coming &#8216;Soon&#8217; For Foundation Series Cyberbeast Customers</a></li>
</ul>
Consumer
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39834307/dominos-pizza-suspends-1-100-global-net-store-outlook-after-q2-earnings-stock-tumbles">Domino&#8217;s Pizza Suspends 1,100+ Global Net Store Outlook After Q2 Earnings, Stock Tumbles</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39833776/hyatt-eyes-standard-international-to-expand-luxury-portfolio-report">Hyatt Eyes Standard International To Expand Luxury Portfolio: Report</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39833284/why-chuys-holdings-shares-are-trading-higher-by-47-here-are-20-stocks-moving-premarket">Why Chuy&#8217;s Holdings Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39833178/whats-going-on-with-ford-motor-stock-premarket-thursday">What&#8217;s Going On With Ford Motor Stock Premarket Thursday?</a></li>
</ul>
Industrial
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39837066/alaska-airlines-reports-mixed-q2-results-and-cautious-q3-outlook-enhances-premium-services">Alaska Airlines Reports Mixed Q2 Results And Cautious Q3 Outlook, Enhances Premium Services</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39836988/boeing-workers-vote-for-strike-mandate">Boeing Workers Vote For Strike Mandate</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39835233/why-electric-aircraft-manufacturer-lilium-shares-are-surging-premarket-thursday">Why Electric Aircraft Manufacturer Lilium Shares Are Surging Premarket Thursday</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39833686/c-130j-takes-on-new-role-lockheed-martin-delivers-aerial-spray-aircraft">C-130J Takes on New Role: Lockheed Martin Delivers Aerial Spray Aircraft</a></li>
</ul>
Healthcare
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/07/39835260/exclusive-haystack-oncology-inks-research-collaboration-with-lisata-therapeutics-to-use-haystack-">EXCLUSIVE: Haystack Oncology Inks Research Collaboration With Lisata Therapeutics To Use Haystack MRD Technology To Evaluate Pancreatic Cancer Therapy Efficacy</a></li>
<li><a href="https://www.benzinga.com/news/earnings/24/07/39831467/abbott-gears-up-for-q2-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-a">Abbott Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>
General
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39831371/chewy-founder-gamestop-ceo-ryan-cohen-posts-trump-665-times-on-elon-musks-x-cryptic-message-has-">Chewy Founder, GameStop CEO Ryan Cohen Posts &#8216;TRUMP&#8217; 665 Times On Elon Musk&#8217;s X: Cryptic Message Has Internet Guessing</a></li>
</ul>
Space
<ul>
<li><a href="https://www.benzinga.com/news/24/07/39831791/spacex-unveils-iss-deorbit-vehicle-design-resembling-dragon-spacecraft-with-6x-more-propellant-and-4">SpaceX Unveils ISS Deorbit Vehicle Design Resembling Dragon Spacecraft With &#8216;6X More Propellant And 4X Power</a></li>
<li><a href="https://www.benzinga.com/news/24/07/39830816/elon-musks-spacex-announces-starlink-now-connects-400k-canadians-or-3-homes-in-the-country">Elon Musk&#8217;s SpaceX Announces Starlink Now Connects 400K Canadians Or 3% Homes In The Country</a></li>
</ul>
Energy
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/24/07/39836855/fortescue-delays-green-hydrogen-ambitions-reaffirms-commitment-to-future-projects">Fortescue Delays Green Hydrogen Ambitions, Reaffirms Commitment To Future Projects</a></li>
</ul>
Image: Tamim Tarin from Pixabay

$BTC

$ETH

Bitcoin Spot ETFs Continue Inflow Streak; Trump's Taiwan Comments And Biden's Trade Plans Trigger Semiconductor Selloff - Top Headlines Today While US Slept

RBC Capital analyst Greg Pardy reiterates Cenovus Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CVE#TSX">CVE</a>) with a Outperform and maintains C$33 price target.

Reiteration

TSX:CVE

RBC Capital Reiterates Outperform on Cenovus Energy, Maintains C$33 Price Target

U.S. Judge Dismisses Most Of SEC Lawsuit Accusing SolarWinds Of Concealing Cyber Risks Prior To Hacking

7 analysts have expressed a variety of opinions on U.S. Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USB#NYSE">USB</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $45.43, along with a high estimate of $49.00 and a low estimate of $42.00. Marking an increase of 1.34%, the current average surpasses the previous average price target of $44.83. 
<img src="https://www.benzinga.com/files/images/story/2024/1721311329_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of U.S. Bancorp's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Peter Winter</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Neutral</td>
<td>$49.00</td>
<td>$44.00</td>
</tr>
<tr>
<td>Ken Usdin</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$42.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Vivek Juneja</td>
<td>JP Morgan</td>
<td>Announces</td>
<td>Neutral</td>
<td>$43.50</td>
<td>-</td>
</tr>
<tr>
<td>Vijay Kumar</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$48.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Betsy Graseck</td>
<td>Morgan Stanley</td>
<td>Maintains</td>
<td>Equal-Weight</td>
<td>$45.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Gerard Cassidy</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$47.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Vivek Juneja</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$43.50</td>
<td>$45.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to U.S. Bancorp. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of U.S. Bancorp compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for U.S. Bancorp's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into U.S. Bancorp's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/USB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on U.S. Bancorp analyst ratings.</a>
<h2>Discovering U.S. Bancorp: A Closer Look</h2>
As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in roughly 26 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
<h3>U.S. Bancorp: Delving into Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining U.S. Bancorp's financials over 3 months reveals challenges. As of 31 March, 2024, the company experienced a decline of approximately -6.39% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 18.09%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): U.S. Bancorp's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.49%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): U.S. Bancorp's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.18%, the company may face hurdles in achieving optimal financial returns.
Debt Management: U.S. Bancorp's debt-to-equity ratio is below the industry average. With a ratio of 1.43, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Basics of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Closer Look at 7 Analyst Recommendations For U.S. Bancorp

Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on Principal Finl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PFG#NASDAQ">PFG</a>) in the last three months.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $88.0, a high estimate of $99.00, and a low estimate of $76.00. This current average reflects an increase of 6.54% from the previous average price target of $82.60. 
<img src="https://www.benzinga.com/files/images/story/2024/1721311306_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
A comprehensive examination of how financial experts perceive Principal Finl Gr is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Suneet Kamath</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$76.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$94.00</td>
<td>$87.00</td>
</tr>
<tr>
<td>Wilma Burdis</td>
<td>Raymond James</td>
<td>Announces</td>
<td>Strong Buy</td>
<td>$99.00</td>
<td>-</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$96.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Suneet Kamath</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$78.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>Edward Kelly</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$85.00</td>
<td>$91.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Principal Finl Gr. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Principal Finl Gr compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Principal Finl Gr's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Capture valuable insights into Principal Finl Gr's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PFG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Principal Finl Gr analyst ratings.</a>
<h2>Get to Know Principal Finl Gr Better</h2>
Principal Financial Group Inc is a leader in Global investment management offering businesses, individuals and institutional clients a wide range of financial products and services, including retirement, asset management and insurance through diverse family of financial services companies. It operates in four business segments that are Retirement and Income Solutions, Principal Global Investors, Principal International, and United States Insurance Solutions. The company receives maximum revenue in the form of premiums.
<h3>Breaking Down Principal Finl Gr's Financial Performance</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Positive Revenue Trend: Examining Principal Finl Gr's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 43.79% as of 31 March, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: Principal Finl Gr's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 13.14%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 4.82%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Principal Finl Gr's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.17%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Principal Finl Gr's debt-to-equity ratio is below the industry average at 0.36, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Significance of Analyst Ratings Explained</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Where Principal Finl Gr Stands With Analysts

Dividends

PPG Board Approves 3-Cent Increase In Quarterly Dividend From $0.65 To $0.68 Cents Per Share; Payable September 12 To Shareholders Of Record August 12

Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) in the last three months.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Petco Health and Wellness and provided 12-month price targets. The average target is $3.71, accompanied by a high estimate of $5.00 and a low estimate of $1.75. Marking an increase of 7.85%, the current average surpasses the previous average price target of $3.44. 
<img src="https://www.benzinga.com/files/images/story/2024/1721311285_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Petco Health and Wellness. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$5.00</td>
<td>$4.00</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$4.00</td>
<td>$4.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$3.00</td>
<td>$2.70</td>
</tr>
<tr>
<td>Anna Andreeva</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$5.00</td>
<td>$5.00</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$4.00</td>
<td>$3.00</td>
</tr>
<tr>
<td>Michael Lasser</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$3.25</td>
<td>$2.50</td>
</tr>
<tr>
<td>Steven Zaccone</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$1.75</td>
<td>$2.85</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Petco Health and Wellness. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Petco Health and Wellness compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Petco Health and Wellness's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/WOOF/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Petco Health and Wellness analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Delving into Petco Health and Wellness's Background</h2>
Petco Health and Wellness Co Inc is a pet health and wellness company focused on improving the lives of pets, pet parents, and its partners with approximately 1,423 pet care centers offering pet care products such as puppy food, treats, nutrition, and supplies through retail outlets and online platforms. The company generates revenue from the sale of products and services such as dog and cat food, supplies, and companion animals, among others.
<h3>Understanding the Numbers: Petco Health and Wellness's Finances</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Petco Health and Wellness's revenue growth over a period of 3 months has faced challenges. As of 30 April, 2024, the company experienced a revenue decline of approximately -1.72%. This indicates a decrease in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -3.04%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -3.96%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Petco Health and Wellness's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -0.88%, the company may face hurdles in achieving optimal financial performance.
Debt Management: Petco Health and Wellness's debt-to-equity ratio stands notably higher than the industry average, reaching 2.56. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Basics of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

WOOF

Peeling Back The Layers: Exploring Petco Health and Wellness Through Analyst Insights

Everest Metals Corporation Limited (AU:EMC) has released an update. Everest Metals Corporation Ltd has announced a new placement, proposing the iss...

Everest Metals Announces Major Securities Issue

Everest Metals Corporation Limited (AU:EMC) has released an update. Everest Metals Corporation Limited has announced an upcoming General Meeting fo...

Everest Metals Schedules Shareholder Meeting

Everest Metals Corporation Limited (AU:EMC) has released an update. Everest Metals Corporation Limited (EMC) has strategically acquired the Mukinbu...

Everest Metals Advances Uranium Strategy with Cobold Deal

Everest Metals Corporation Limited (AU:EMC) has released an update. Everest Metals Corporation Limited (EMC) has announced its strategic involvemen...

Everest Metals Backs Cobold Metals in Uranium IPO

Everest Metals Corporation Limited (AU:EMC) has released an update. Everest Metals Corporation Limited has announced promising developments at its ...

Everest Metals Hits High-Grade Gold in Revere Project

Everest Metals Corporation Limited (AU:EMC) has released an update. Everest Metals Corporation Limited has announced a significant find of high-gra...

Everest Metals Discovers High-Grade Gold

Everest Metals Corporation Limited (AU:EMC) has released an update. Everest Metals Corporation Limited (EMC) is on the verge of establishing itself...

Everest Metals Poised to Transform Rubidium Market

Everest Metals Corporation Limited (AU:EMC) has released an update. Everest Metals Corporation Limited announced the results of its recent General ...

Everest Metals Shareholders Approve All Resolutions

Everest Metals Corporation Limited (AU:EMC) has released an update. Everest Metals Corporation Ltd has successfully completed a share placement, is...

Everest Metals Completes $2.2M Share Placement

Everest Metals Corporation Limited (AU:EMC) has released an update. Everest Metals Corporation Ltd has announced the application for quotation of 2...